Jens Waldmann

Papers

Total Citations

H-Index

About

Jens Waldmann is a leading surgical researcher whose work focuses on advancing minimally invasive techniques for complex endocrine and pancreatic conditions, particularly in patients with rare genetic syndromes. His most cited study, a 2016 investigation comparing minimally invasive versus open pancreatic surgery in patients with Multiple Endocrine Neoplasia Type 1 (MEN1), has garnered 53 citations and remains a pivotal reference in the field. This work directly addressed a critical gap in the literature, demonstrating that minimally invasive approaches can be safely and effectively applied to pancreatic neuroendocrine neoplasms in MEN1 patients—a population with unique surgical challenges. By providing robust comparative outcomes, Waldmann’s research has helped shift clinical practice toward less invasive options, potentially reducing recovery times and complications for these complex patients. His contributions are particularly valuable for surgeons and endocrinologists managing hereditary tumor syndromes, offering evidence-based guidance where data were previously scarce. Through this landmark study, Waldmann has established himself as an authority on the surgical management of MEN1-related pancreatic disease, influencing both operative decision-making and future research directions in minimally invasive endocrine surgery.